Brian T. Powl serves as Executive at FATE THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Brian T. Powl has executed 9 insider transactions totaling $197.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 2, 2026 involved receiving (via award) 100,000 shares valued at $0.
Brian T. Powl currently holds 100,000 shares of FATE THERAPEUTICS INC (FATE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brian T. Powl has been a net seller of FATE stock. They have purchased $0 and sold $197.6K worth of shares.
Brian T. Powl's most recent insider trade was on Jan 2, 2026, when they sold 100,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 14, 2025 | KURA | $99.4K | Sale | 8,887 | $11.18 | Discretionary |
| Nov 13, 2025 | KURA | $0 | Award | 48,900 | $N/A | Discretionary |
| Sep 29, 2025 | KURA | $79.5K | Sale | 8,891 | $8.94 | Discretionary |
| Sep 27, 2025 | KURA | $0 | Award | 48,900 | $N/A | Discretionary |
| Jan 2, 2024 | KURA | $0 | Award | 15,000 | $N/A | Discretionary |
| Jul 5, 2023 | FATE | $18.8K | Sale | 3,854 | $4.87 | Discretionary |
| Jun 27, 2022 | FATE | $0 | Award | 45,000 | $N/A | Discretionary |